Myotonic Dystrophy affects more than just skeletal muscles; it commonly involves several other organ systems as well. Beyond the muscles you see weakness and delayed relaxation (myotonia), the disease often touches the heart, the lungs, the digestive tract, and the eyes. Cardiac involvement can include conduction defects and arrhythmias, so heart rhythm problems are a real concern. Respiratory muscles, including the diaphragm and chest wall, can weaken, leading to breathing difficulties and sleep-related breathing issues. The GI system can be affected by impaired motility and swallowing difficulties, causing dysphagia and other GI symptoms. Ocular involvement frequently includes cataracts and other eye changes. Because these systems can all be affected, the combination of cardiac, respiratory, GI, and ocular involvement best reflects the systemic nature of the disease.

Duchenne muscular dystrophy commonly progresses with early and severe weakness of the respiratory muscles, including the diaphragm and intercostals. As these muscles weaken, effective coughing declines and nighttime (and sometimes daytime) ventilation becomes inadequate, leading to hypoventilation, atelectasis, and pneumonia risk. Because of this, respiratory support and airway clearance strategies are a standard part of care—examples include noninvasive ventilation at night and devices or techniques to help clear secretions (cough-assist devices, chest physiotherapy, and regular airway clearance routines). Becker muscular dystrophy can involve breathing difficulties, but it typically starts later and progresses more slowly, so respiratory support is not as universally required as in Duchenne. Facioscapulohumeral muscular dystrophy mainly affects shoulder and facial muscles, with respiratory involvement being less common and not routinely part of standard care. Myotonic dystrophy type 2 can have respiratory weakness in some individuals, especially with advanced disease, but again it's not as consistently addressed with routine respiratory support as in Duchenne. So the best answer is Duchenne muscular dystrophy because its pattern of rapid, early respiratory muscle decline makes airway clearance and respiratory support a standard part of management.

Adaptive equipment refers to devices that help a person with muscular dystrophy perform daily tasks and stay independent despite muscle weakness. In MD, mobility and self-care can become progressively harder, so tools like wheelchairs provide mobility, lifts assist with transfers between bed, chair, or shower, shower chairs support safe bathing, and splints help stabilize joints and prevent contractures. These items modify how activities are done or how the person moves, enhancing safety and independence. Prescription medications and respiratory therapy are treatments, not equipment. Exercise bands are tools for therapy and conditioning, not adaptive devices used to perform daily tasks.

When DMD progresses, weakness of the breathing muscles, especially the diaphragm, leads to nocturnal hypoventilation and sleep-disordered breathing. The best noninvasive approach to manage this is noninvasive ventilation, which delivers positive airway pressure through a mask or similar interface to assist breathing during sleep. This support increases tidal volumes, improves overnight gas exchange, reduces carbon dioxide buildup, and often enhances daytime energy and quality of life, all without needing an artificial airway. Supplemental oxygen alone won’t correct the underlying hypoventilation and can even worsen CO2 retention in a ventilatory failure. Chest physiotherapy helps clear secretions but doesn’t provide ventilation during sleep. Invasive ventilation involves an airway through a tube and is not the noninvasive option described here.